Safety of contemporary menopausal hormonal therapy based on low doses of oestradiol and NETA

Tomasz Stetkiewicz; Grzegorz Stachowiak

eISSN: 2299-0038
ISSN: 1643-8876

Menopause Review/Przegląd Menopauzalny

Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

2/2011
vol. 10

Send email

Copy url:

abstract:

Review paper

Safety of contemporary menopausal hormonal therapy based on low doses of oestradiol and NETA

Tomasz Stetkiewicz

,

Grzegorz Stachowiak

Przegląd Menopauzalny 2011; 2: 153–156

Online publish date: 2011/04/28

View full text Get citation

Results of the large clinical trials Women’s Health Initiative (WHI), the Heart and Estrogen/progestin Replacement Study (HERS), and the Million Women Study (MWS) changed doctors’ and patients’ view of hormonal therapy and narrowed the indications for this treatment. Contemporary menopausal hormonal therapy, besides therapeutic safety, has to be highly individualized – adjusted to a particular patient’s needs, “tailor-made” for her (tailored therapy), and ensure understanding and compliance with the treatment regimen.

The main advantage of low dose hormonal therapy is a similar therapeutic effect to therapy based on higher doses but with lower probability of adverse effects.

To meet therapy safety and individualization requirements, one should remember about the correct choice of progestin, regarding possible adverse effects of this compound

keywords:

Safety of contemporary menopausal hormonal therapy based on low doses of oestradiol and NETA

Tomasz Stetkiewicz , Grzegorz Stachowiak

hormonal therapy, menopause, safety, low doses, NETA

Tomasz Stetkiewicz

,

Grzegorz Stachowiak